Announcements Trials

Browse Landscape

Phase

Phase NA 19 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 277 Neoplasms 202 Prostatic Neoplasms 118 Polycystic Ovary Syndrome 114 Colorectal Neoplasms 104 Carcinoma, Hepatocellular 103 Carcinoma, Non-Small-Cell Lung 88 Lung Neoplasms 70 Stomach Neoplasms 62 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Pain 59 Neoplasm Metastasis 54 Multiple Myeloma 52 Pancreatic Neoplasms 46 Keratosis, Actinic 46 Pain, Postoperative 43 Head and Neck Neoplasms 43 Leukemia, Myeloid, Acute 40 Leiomyoma 39 Recurrence 38 Liver Neoplasms 38 Colonic Neoplasms 37 Uterine Cervical Neoplasms 35 Lymphoma 35 Brain Neoplasms 34 Infertility 33 Papillomavirus Infections 32 Ovarian Neoplasms 31 Lymphoma, Follicular 31 Lymphoma, Non-Hodgkin 30

Interventions

palbociclib 1 exemestane 1 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Letrozole 1 Fulvestrant 1 Epirubicin 1 Drug Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Patient Acceptance of Health Care × Clear all

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡